Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
European Radiology
Published in: European Radiology 6/2013

01-06-2013 | Neuro

Immediate post-operative MRI suggestive of the site and timing of glioblastoma recurrence after gross total resection: a retrospective longitudinal preliminary study

Authors: Thibault Smets, Tévi Morel Lawson, Cécile Grandin, Aleksandar Jankovski, Christian Raftopoulos

Published in: European Radiology | Issue 6/2013

Login to get access

Abstract

Objectives

To retrospectively identify morphological and physiological post-operative magnetic resonance imaging (MRI) characteristics predictive of glioblastoma recurrences after gross total resection (gross-TR).

Methods

Resection margins of 24 glioblastoma were analysed immediately post-operatively (MRI ≤ 2 h) and early post-operatively (24 h ≤ MRI ≤ 48 h), and subdivided into areas with and without subtle contrast enhancement previously considered non-specific. On follow-up MRI, tumour regrowth areas were subdivided according to recurrence extent (focally/extended) and delay (≤6 and ≥12 months). Co-registration of pre-operative, immediately post-operative and early post-operative MRI with the first follow-up MRI demonstrating recurrence authorised their morphological (contrast enhancements) and physiological (rCBV) characterisation.

Results

Morphologically, on immediately post-operative MRI, micro-nodular and frayed enhancements correlate significantly with early recurrences (≤6 months). After gross-TR the absence of these enhancements is associated with a significant increase in progression-free survival (61 vs 15 weeks respectively) and overall survival (125 vs 51 weeks respectively). Physiologically, areas with a future focal recurrence have a trend toward higher rCBV than other areas.

Conclusion

Immediately post-operative topography of micro-nodular and frayed enhancements is suggestive of recurrence location and delay. Absence of such enhancements is associated with a fourfold increase in progression-free survival and a 2.5-fold increase in overall survival.

Key Points

• Immediately post-operative MRI reveals contrast enhancement after glioblastoma gross total resection.
• Immediately post-operative micro-nodular and frayed enhancement correlate with early recurrence.
• Absence of micro-nodular/frayed enhancement is associated with 61 weeks’ progression-free survival.
• Absence of micro-nodular/frayed enhancement is associated with 125 weeks’ overall survival.
Literature
1.
2.
Albert FK, Forsting M, Sartor K, Adams HP, Kunze S (1994) Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery 34:45–60, discussion 60-41PubMedCrossRef
3.
Allahdini F, Amirjamshidi A, Reza-Zarei M, Abdollahi M (2010) Evaluating the prognostic factors effective on the outcome of patients with glioblastoma multiformis: does maximal resection of the tumor lengthen the median survival? World Neurosurg 73:128–134, discussion e116PubMedCrossRef
4.
Sanai N, Polley MY, Mcdermott MW, Parsa AT, Berger MS (2011) An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg 115:3–8PubMedCrossRef
5.
Lacroix M, Abi-Said D, Fourney DR et al (2001) A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95:190–198PubMedCrossRef
6.
Hentschel SJ, Sawaya R (2003) Optimizing outcomes with maximal surgical resection of malignant gliomas. Cancer Control 10:109–114PubMed
7.
Kuhnt D, Becker A, Ganslandt O, Bauer M, Buchfelder M, Nimsky C (2011) Correlation of the extent of tumor volume resection and patient survival in surgery of glioblastoma multiforme with high-field intraoperative MRI guidance. Neuro Oncol 13:1339–1348PubMedCrossRef
8.
Jeremic B, Grulicic D, Samardzic M et al (1997) The effect of extent of tumor resection on the outcome of combined therapy in patients with glioblastoma multiforme. Srp Arh Celok Lek 125:93–98PubMed
9.
Ushio Y, Kochi M, Hamada J, Kai Y, Nakamura H (2005) Effect of surgical removal on survival and quality of life in patients with supratentorial glioblastoma. Neurol Med Chir (Tokyo) 45:454–460, discussion 460-451CrossRef
10.
Vidiri A, Carapella CM, Pace A et al (2006) Early post-operative MRI: correlation with progression-free survival and overall survival time in malignant gliomas. J Exp Clin Cancer Res 25:177–182PubMed
11.
Stewart LA (2002) Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 359:1011–1018PubMedCrossRef
12.
Li SW, Qiu XG, Chen BS et al (2009) Prognostic factors influencing clinical outcomes of glioblastoma multiforme. Chin Med J (Engl) 122:1245–1249
13.
Mcgirt MJ, Chaichana KL, Gathinji M et al (2009) Independent association of extent of resection with survival in patients with malignant brain astrocytoma. J Neurosurg 110:156–162PubMedCrossRef
14.
Murakami R, Hirai T, Nakamura H et al (2010) Recurrence patterns of glioblastoma treated with postoperative radiation therapy: relationship between extent of resection and progression-free interval. Int J Radiat Oncol Biol Phys 78(3 Suppl 1):S289–S290CrossRef
15.
Ewelt C, Goeppert M, Rapp M, Steiger HJ, Stummer W, Sabel M (2011) Glioblastoma multiforme of the elderly: the prognostic effect of resection on survival. J Neurooncol 103:611–618PubMedCrossRef
16.
Massey V, Wallner KE (1990) Patterns of second recurrence of malignant astrocytomas. Int J Radiat Oncol Biol Phys 18:395–398PubMedCrossRef
17.
Hess CF, Schaaf JC, Kortmann RD, Schabet M, Bamberg M (1994) Malignant glioma: patterns of failure following individually tailored limited volume irradiation. Radiother Oncol 30:146–149PubMedCrossRef
18.
Wick W, Stupp R, Beule AC et al (2008) A novel tool to analyze MRI recurrence patterns in glioblastoma. Neuro Oncol 10:1019–1024PubMedCrossRef
19.
Schaefer PW, Grant PE, Gonzalez RG (2000) Diffusion-weighted MR imaging of the brain. Radiology 217:331–345PubMed
20.
Di Costanzo A, Scarabino T, Trojsi F et al (2006) Multiparametric 3T MR approach to the assessment of cerebral gliomas: tumor extent and malignancy. Neuroradiology 48:622–631PubMedCrossRef
21.
Khan RB, Gutin PH, Rai SN, Zhang L, Krol G, Deangelis LM (2006) Use of diffusion weighted magnetic resonance imaging in predicting early postoperative outcome of new neurological deficits after brain tumor resection. Neurosurgery 59:60–66, discussion 60–66PubMedCrossRef
22.
Pirzkall A, Mcgue C, Saraswathy S et al (2009) Tumor regrowth between surgery and initiation of adjuvant therapy in patients with newly diagnosed glioblastoma. Neuro Oncol 11:842–852PubMedCrossRef
23.
Khayal IS, Polley MY, Jalbert L et al (2010) Evaluation of diffusion parameters as early biomarkers of disease progression in glioblastoma multiforme. Neuro Oncol 12:908–916PubMedCrossRef
24.
Blasel S, Franz K, Ackermann H, Weidauer S, Zanella F, Hattingen E (2011) Stripe-like increase of rCBV beyond the visible border of glioblastomas: site of tumor infiltration growing after neurosurgery. J Neurooncol 103:575–584PubMedCrossRef
25.
Li Y, Lupo JM, Polley MY et al (2011) Serial analysis of imaging parameters in patients with newly diagnosed glioblastoma multiforme. Neuro Oncol 13:546–557PubMedCrossRef
26.
Stecco A, Pisani C, Quarta R et al (2011) DTI and PWI analysis of peri-enhancing tumoral brain tissue in patients treated for glioblastoma. J Neurooncol 102:261–271PubMedCrossRef
27.
Leysalle A, Haberer S (2010) Mise au point sur la pseudoprogression après chimioradiothérapie dans les glioblastomes. Oncologie 12:559–564CrossRef
28.
Jankovski A, Francotte F, Vaz G et al (2008) Intraoperative magnetic resonance imaging at 3-T using a dual independent operating room-magnetic resonance imaging suite: development, feasibility, safety, and preliminary experience. Neurosurgery 63:412–424, discussion 424–416PubMedCrossRef
29.
Streiner DL, Norman GR (2008) Health measurement scales: a practical guide to their development and use. Oxford University Press, Oxford
30.
Knauth M, Aras N, Wirtz CR, Dorfler A, Engelhorn T, Sartor K (1999) Surgically induced intracranial contrast enhancement: potential source of diagnostic error in intraoperative MR imaging. AJNR Am J Neuroradiol 20:1547–1553PubMed
31.
Ekinci G, Akpinar IN, Baltacioglu F et al (2003) Early-postoperative magnetic resonance imaging in glial tumors: prediction of tumor regrowth and recurrence. Eur J Radiol 45:99–107PubMedCrossRef
32.
Keles GE, Anderson B, Berger MS (1999) The effect of extent of resection on time to tumor progression and survival in patients with glioblastoma multiforme of the cerebral hemisphere. Surg Neurol 52:371–379PubMedCrossRef
33.
Aronen HJ, Gazit IE, Louis DN et al (1994) Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 191:41–51PubMed
34.
Rollin N, Guyotat J, Streichenberger N, Honnorat J, Tran Minh VA, Cotton F (2006) Clinical relevance of diffusion and perfusion magnetic resonance imaging in assessing intra-axial brain tumors. Neuroradiology 48:150–159PubMedCrossRef
35.
Sehgal V, Delproposto Z, Haddar D et al (2006) Susceptibility-weighted imaging to visualize blood products and improve tumor contrast in the study of brain masses. J Magn Reson Imaging 24:41–51PubMedCrossRef
36.
Lupo JM, Cha S, Chang SM, Nelson SJ (2007) Analysis of metabolic indices in regions of abnormal perfusion in patients with high-grade glioma. AJNR Am J Neuroradiol 28:1455–1461PubMedCrossRef
37.
Lehmann P, Saliou G, De Marco G et al (2011) Cerebral peritumoral oedema study: does a single dynamic MR sequence assessing perfusion and permeability can help to differentiate glioblastoma from metastasis? Eur J Radiol 81:522-527
Metadata
Title
Immediate post-operative MRI suggestive of the site and timing of glioblastoma recurrence after gross total resection: a retrospective longitudinal preliminary study
Authors
Thibault Smets
Tévi Morel Lawson
Cécile Grandin
Aleksandar Jankovski
Christian Raftopoulos
Publication date
01-06-2013
Publisher
Springer-Verlag
Published in
European Radiology / Issue 6/2013
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-012-2762-1

Other articles of this Issue 6/2013

European Radiology 6/2013 Go to the issue

Chest

CT protocols in interstitial lung diseases—A survey among members of the European Society of Thoracic Imaging and a review of the literature

Breast

Breast dynamic contrast-enhanced examinations with fat suppression: Are contrast-agent uptake curves affected by magnetic field inhomogeneity?

Neuro

Value of CT angiography for the detection of intracranial vascular lesions in patients with acute severe headache

Computed Tomography

Methodological quality of diagnostic accuracy studies on non-invasive coronary CT angiography: influence of QUADAS (Quality Assessment of Diagnostic Accuracy Studies included in systematic reviews) items on sensitivity and specificity

Pediatric

Whole-body post-mortem computed tomography compared with autopsy in the investigation of unexpected death in infants and children

Health Economy

Cost comparison of nerve root infiltration of the lumbar spine under MRI and CT guidance